FTSE 100 Live: London stocks recover as oil and gold climb on Iran tensionsFebruary 20, 2026Yahoo Finance
Ascendis Pharma (ASND) Revenue Nearly Doubles to €720M in 2025 Fueled by Core Product GrowthFebruary 20, 2026Yahoo Finance
Ascendis Pharma (ASND) Revenue Nearly Doubles to €720M in 2025 Fueled by Core Product GrowthFebruary 20, 2026Yahoo Finance
MKS Inc. (MKSI) Reports $1.03B Q4 2025 Revenue Driven by Electronics & Packaging Segment GrowthFebruary 20, 2026Yahoo Finance
Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine SalesFebruary 20, 2026Yahoo Finance
Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine SalesFebruary 20, 2026Yahoo Finance
Grab Holdings (GRAB) Reports First Year of Net Profitability and 19% Q4 Revenue GrowthFebruary 20, 2026Yahoo Finance
Grab Holdings (GRAB) Reports First Year of Net Profitability and 19% Q4 Revenue GrowthFebruary 20, 2026Yahoo Finance
